CD8A and graft versus host disease: As a subset of regulatory T (Treg) cells, DN T cells can prevent graft-versus-host disease (GVHD) and have therapeutic value for autoimmune disease, depending on their regulatory effects on CD8+ T cells, CD4+ T cells and B cells (4–6).